TITLE

Controversy about the Cardiovascular Safety of Sibutramine

AUTHOR(S)
Scheen, André J.
PUB. DATE
July 2010
SOURCE
Drug Safety;2010, Vol. 33 Issue 7, p615
SOURCE TYPE
Academic Journal
DOC. TYPE
Opinion
ABSTRACT
In this article, the author discusses the cardiovascular safety of sibutamine as the cure of obesity. He agrees that conventional risk-reduction measures such as the use of aspirin and lipid-lowering drugs are proven effective in reducing cardiovascular diseases (CVD) and saving lives of at-risk or obese individuals. He also opines that the research which says that sabutamine may lower the risk of death in overweight is speculative as he sees bias on the conducted research.
ACCESSION #
53384534

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics